BELANTAMAB
UNII 7M3UL8MR2Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Belantamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7M3UL8MR2Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2061894-48-0 and the RxNorm Concept ID (RxCUI) 2387844. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7M3UL8MR2Y

CAS Registry Number

2061894-48-0

RxNorm Concept ID

2387844

Detailed Substance Profile

Preferred Name

BELANTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C171828

National Cancer Institute reference terminology for clinical and research data.

INN ID

10797

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-34

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Belantamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BELANTAMAB

Common Names & Synonyms

BELANTAMAB [INN]

BELANTAMAB [USAN]

BELANTAMAB [WHO-DD]

LMMUNOGLOBULIN G1, ANTI-(TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMANIZED MONOCLONAL GSK2857914 Y1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL GSK2857914 K-CHAIN, DIMER

Systematic Nomenclature

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17 (B-CELL MATURATION PROTEIN, ANTIGEN CD269))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-451) (HUMANIZED VH (HOMO SAPIENS IGHV1-69*06 (84%) (IGHD)-IGHJ4*01 (86%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG1*01 (122-451)) (224-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-33*01 (91%) IGKJ2*02 (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (230-230'':233-233'')-BISDISULFIDE

SYS

External Clinical & Regulatory Resources

Previous UNII7M3S91Y4OO

Next UNII7M430JI73B